Physician profile
Samar H Ibrahim
NPI 1427179423
$26,745.45
in general payments reported to CMS, 2019-2025
7 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,159 · 2022: $4,427 · 2023: $18K · 2024: $150 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $4,325 · Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,000.50 |
| Travel and Lodging | $4,324.56 |
| Food and Beverage | $834.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Albireo Pharma, INC. | $14,029.49 | 2022-2023 | Bylvay |
| Mirum Pharmaceuticals, INC. | $8,180.59 | 2022-2023 | Livmarli |
| Pfizer INC. | $3,404.01 | 2019 | |
| Gilead Sciences, INC. | $754.73 | 2019 | |
| Abiomed | $150.00 | 2024 | |
| Madrigal Pharmaceuticals | $127.95 | 2025 | Rezdiffra |
| Abbott Laboratories | $98.68 | 2025 | Ensite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samar Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.